Neuroprotection Compound Library
                    
                    
                    The molecular mechanisms of programmed cell death  associated with neurodegenerative diseases have been one of the hot topics of  research for many years. Neurodegenerative diseases are characterized by  progressive neuronal dysfunction and death of neurons, such as Alzheimer's  disease, Parkinson's disease, and multiple sclerosis (MS). Neuroprotection can  protect neurons from different pathological factors in neurodegenerative  diseases. Current studies have shown that in the treatment of neurodegenerative  diseases, neuroprotective agents cannot reverse existing damage, but they can  protect against further neurological damage and slow down the degenerative  effects of the central nervous system.
BOC Sciences can provide a high-quality  neuroprotection compound library which can be used as a useful tool in  neuroprotective drug discovery.
 Figure 1. Representation of  the mechanism of neuroprotection in oxidative stress. (Egea, J.; et al. 2015)
  Figure 1. Representation of  the mechanism of neuroprotection in oxidative stress. (Egea, J.; et al. 2015)
Library  Design
- Our unique neuroprotection compound  library contains 700 compounds, which is designed for high throughput screening  (HTS) and high content screening (HCS) campaigns
- Targets including: calcium channel, sodium  channel, adenosine A1 receptor, PI3K, etc
- The composition of this neuroprotection  compound library:
| Calcium ChannelSodium ChanneliGluRApoptosisPotassium ChannelWntEndogenous MetaboliteAutophagyGABA Receptorβ-cateninNO SynthasemGluRReactive Oxygen SpeciesNF-κBBacterialAdenosine ReceptorCOXAktERKParasiteCytochrome P450Phosphodiesterase (PDE)Monoamine OxidaseSigma Receptor5-HT ReceptorTRP ChannelAChEAdrenergic ReceptorAmyloid-βDopamine ReceptorGSK-3
 | HIVPARPAntibioticInfluenza VirusPI3KFerroptosisTGF-beta/SmadTNF ReceptorAngiotensin ReceptorDrug MetaboliteInterleukin RelatedmAChRP2X ReceptorPorcupinePPARVirus ProteaseCasein KinaseCaspaseDNA/RNA SynthesisHCVHSVMDM-2/p53MEKMitochondrial MetabolismMMPP-glycoproteinp38 MAPKSirtuinSTATTrk ReceptorAMPK
 | T Angiotensin-converting    Enzyme (ACE)Beta-secretaseCannabinoid ReceptorCarbonic AnhydraseCDKChloride ChannelEstrogen Receptor/ERRFungalGlucosidaseHDACHistamine ReceptorHistone MethyltransferaseHSPJAKJNKLPL ReceptorMAP4KMitophagynAChRNOD-like Receptor (NLR)NotchPKCProstaglandin ReceptorROCKAcetyl-CoA CarboxylaseAldose ReductaseAndrogen ReceptorAryl Hydrocarbon ReceptorBcl-2 FamilyCarboxypeptidaseCathepsi
 | 
Neuroprotection Compound Library  Characteristics
- No PAINS or toxic substances/unwanted  functions: filtered by strict ‘Ro5-like’ physicochemical and most stringent  in-house structural filters
- Confirmed bioactivity and safety by preclinical  studies and clinical trials
- Structural diversity, significant  efficacy, and cellular penetration
- Structural document, IC50, and other  chemical and biological data are provided
- Tanimoto index ≥ 0.8
- All compounds are continually updated
- Compound cherry-picking service is  provided
What  We Deliver
- Delivered within 2 weeks in any  customer-preferred format
- Powders, dry films or DMSO solutions  formatted in vials, 96 or 384-well plates
- All compounds have a minimum purity of 90%  assessed by 1H NMR and HPLC
- Analytical data is provided
BOC Sciences provides professional,  rapid and high-quality services of Neuroprotection Compound Library design at  competitive prices for global customers. Personalized and customized services  of Neuroprotection Compound Library design can satisfy any innovative  scientific study demands. Our clients have direct access to our staff and  prompt feedback to their inquiries. If you are interested in our services,  please contact us immediately!
Reference
- Egea,  J.; et al.  Melatonin-sulforaphane hybrid ITH12674 induces neuroprotection in oxidative  stress conditions by a 'drug-prodrug' mechanism of action. British Journal of Pharmacology.  2015. 172(7): 1807-1821.